SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021125
Filing Date
2018-08-09
Accepted
2018-08-09 17:11:40
Documents
64
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20180630.htm 10-Q 1963305
2 EX-10.1 vktx-ex101_126.htm EX-10.1 624590
3 EX-12.1 vktx-ex121_89.htm EX-12.1 119950
4 EX-31.1 vktx-ex311_6.htm EX-31.1 20487
5 EX-31.2 vktx-ex312_7.htm EX-31.2 20577
6 EX-32.1 vktx-ex321_8.htm EX-32.1 12861
7 GRAPHIC gmbv2vpxku3i000001.jpg GRAPHIC 18400
  Complete submission text file 0001564590-18-021125.txt   8528982

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vktx-20180630.xml EX-101.INS 1812033
9 XBRL TAXONOMY EXTENSION SCHEMA vktx-20180630.xsd EX-101.SCH 56008
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20180630_cal.xml EX-101.CAL 38381
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20180630_def.xml EX-101.DEF 193612
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20180630_lab.xml EX-101.LAB 417708
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20180630_pre.xml EX-101.PRE 333086
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 181006287
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences